- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 305/06 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring atoms
Patent holdings for IPC class C07D 305/06
Total number of patents in this class: 295
10-year publication summary
23
|
13
|
21
|
25
|
20
|
30
|
20
|
26
|
16
|
8
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Changzhou Tronly Advanced Electronic Materials Co., Ltd. | 77 |
12 |
Changzhou Tronly New Electronic Materials Co.,Ltd. | 76 |
11 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 3143 |
8 |
H. Lundbeck A/S | 1239 |
8 |
BASF SE | 20912 |
7 |
F. Hoffmann-La Roche AG | 7930 |
6 |
Hoffmann-La Roche Inc. | 3408 |
6 |
DIC Corporation | 3786 |
6 |
The Salk Institute for Biological Studies | 445 |
6 |
Shijiazhuang Chengzhi Yonghua Display Material Co., Ltd. | 198 |
6 |
Sanofi | 4040 |
6 |
FUJIFILM Corporation | 29329 |
5 |
Canopy Growth Corporation | 220 |
5 |
Hubei Gurun Technology Co., Ltd | 32 |
5 |
Xwpharma Ltd. | 57 |
5 |
Syngenta Participations AG | 1906 |
4 |
Iowa State University Research Foundation, Inc. | 769 |
4 |
Vivace Therapeutics, Inc. | 30 |
4 |
Grey Wolf Therapeutics Limited | 16 |
4 |
AstraZeneca AB | 2923 |
3 |
Other owners | 174 |